Back to MW MARSHALL WACE, LLP

TVTXTVTX
Showing 7 of 16 quarters

Position history for MWMARSHALL WACE, LLP's holdings in TRAVERE THERAPEUTICS INC

MARSHALL WACE, LLP holds 1.3M shares of TVTX (TRAVERE THERAPEUTICS INC), worth $75.7M as of 2026-Q2. The position was increased (+646.7% shares). TVTX represents 0.1% of MARSHALL WACE, LLP's portfolio.

Current Value

$75.7M

Current Shares

1.3M

Total Value Change

+$74.2M

Total Shares Change

+1.2M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
1.3M
+646.7%
$75.7M0.1%$56.81
48
2026-Q1
Decreased
178,536
-17.8%
$5.3M0.0%$28.27
0
2025-Q4
Decreased
217,171
-63.2%
$8.3M0.0%$37.68
0
2025-Q3
Decreased
590,051
-20.6%
$14.1M0.0%$24.04
0
2025-Q2
New
742,725
-
$11M0.0%$14.77
38
2024-Q4
Exited
0
-100.0%
$00.0%$17.32
0
2024-Q3
New
111,341
-
$1.6M0.0%$14.01
35

Other major holders of TVTX: BlackRock, Inc., FMR LLC, Janus Henderson Group Ltd.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used